Laboratorios Rovi, Insud Pharma and Ministry of Science form partnership to research advanced therapies
Link Securities| In a Significant Event sent to the National Securities Market Commission (CNMV) by the company, the pharmaceutical company Laboratorios Rovi (ROVI) announced that it has reached an agreement with Insud Pharma and Innvierte Economía Sostenible, dependent on the Ministry of Science, for the constitution of a commercial company with public-private capital dedicated to the research and development of advanced therapies. The agreement, which was approved on Tuesday by…